SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Andrew H who wrote (11943)12/1/1997 3:19:00 PM
From: Andrew H  Read Replies (1) | Respond to of 32384
 
Looking a lot more serious for Rezulin. Many analysts are cutting their earnings estimates. Apparently users will have to have liver function tests 10 times/year. That will deter some. One analyst gives it a 20-30% chance of being pulled from the market. Bad news for diabetes sufferers but good news for BMY, LGND and LLY. LGND now up 5/8 at 3/8 by 7/16. My guess is a good part of the gain is based on the LLY news.